Vascular rejection in cardiac allograft vasculopathy: Impact on graft survival

被引：0
|
作者：
Nair, Nandini [1 ]
机构：
[1] Texas Tech Univ, Dept Med, Div Cardiol, Hlth Sci Ctr, Lubbock, TX 79430 USA
来源：
FRONTIERS IN CARDIOVASCULAR MEDICINE | 2022年 / 9卷
关键词：
anti HLA antibodies; anti-vimentin antibodies; antibody-mediated rejection; donor specific antibodies; cardiac transplantation; ANTIBODY-MEDIATED REJECTION; DONOR-SPECIFIC ANTIBODIES; LEUKOCYTE ANTIGEN ANTIBODIES; ENDOTHELIAL-CELL ANTIBODIES; HEART-TRANSPLANTATION; ANTIVIMENTIN ANTIBODIES; HLA ANTIBODIES; INTERNATIONAL SOCIETY; INDEPENDENT PREDICTOR; HUMORAL IMMUNITY;
D O I：
10.3389/fcvm.2022.919036
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页数：6
相关论文
共 50 条
  • [41] Impact of Immunosuppressive Drugs on the Development of Cardiac Allograft Vasculopathy
    Dandel, Michael
    Hetzer, Roland
    CURRENT VASCULAR PHARMACOLOGY, 2010, 8 (05) : 706 - 719
  • [42] IMPACT OF POSTTRANSPLANT WEIGHT GAIN ON CARDIAC ALLOGRAFT VASCULOPATHY
    Hoefle, G.
    Saely, C. H.
    Martinelli, M.
    Meier, B.
    Carrel, T.
    Seitz, M.
    Villiger, P. M.
    Mohacsi, P.
    CARDIOLOGY, 2013, 125 : 120 - 120
  • [43] Impact of Statin Intensity on the Development of Cardiac Allograft Vasculopathy
    Goehring, K.
    Kuan, W.
    Sieg, A.
    Dawson, K. L.
    Kolodziej, A. R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 761 - 761
  • [44] Impact of posttransplant weight gain on cardiac allograft vasculopathy
    Hoefle, Guenter
    Saely, Christoph H.
    Martinelli, Michele
    Hullin, Roger
    Meier, Bernhard
    Carrel, Thierry
    Seitz, Michael
    Villiger, Peter M.
    Mohacsi, Paul
    INTERNATIONAL JOURNAL OF OBESITY, 2007, 31 : S138 - S138
  • [45] Late Cardiac Allograft Failure, Cardiac Allograft Vasculopathy, and Antibody-Mediated Rejection: Untangling Some Knots?
    Burke, M. M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 (01) : 9 - 10
  • [46] Relevance of HLA Ab and a donor specific FCXM to rejection and graft survival in cardiac allograft recipients
    Kerman, R
    Radovancevic, B
    Frazier, OH
    Smart, F
    Acordia, N
    Juarez, P
    Nemeth, LA
    Kahan, B
    Przybylowski, P
    HUMAN IMMUNOLOGY, 2004, 65 : S37 - S37
  • [47] Late antibody-mediated rejection after heart transplantation: Mortality, graft function, and fulminant cardiac allograft vasculopathy
    Coutance, Guillaume
    Ouldamar, Salima
    Rouvier, Philippe
    Saheb, Samir
    Suberbielle, Caroline
    Brechot, Nicolas
    Hariri, Sarah
    Lebreton, Guillaume
    Leprince, Pascal
    Varnous, Shaida
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 34 (08): : 1050 - 1057
  • [48] Earlier Cardiac Allograft Vasculopathy and Graft Failure in Pediatric Heart Transplant Recipients After Rejection with Severe Hemodynamic Compromise
    Kleinmahon, J. A.
    Gralla, J.
    Auerbach, S. R.
    Wallis, G. A.
    Ramakrishnan, K.
    Singh, R.
    Caldwell, R. L.
    Kirk, R.
    Savage, A. J.
    Henderson, H. T.
    Everitt, M. D.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (04): : S191 - S192
  • [49] PCI DOES NOT PROLONG SURVIVAL IN PATIENTS WITH CARDIAC ALLOGRAFT VASCULOPATHY
    Agarwal, Shikhar
    Bajaj, Navkaranbir
    Parashar, Akhil
    Modi, Dhruv
    Tuzcu, E. Murat
    Starling, Randall
    Oliveira, Guilherme
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E1696 - E1696
  • [50] Dabrafenib/pembrolizumab/trametinibLack of efficacy, fatal allograft rejection and cardiac allograft vasculopathy: case report
    Reactions Weekly, 2022, 1932 (1) : 226 - 226
12345